Incidence of transaminitis among HIV-infected patients with occult hepatitis B

Journal of Clinical Virology

Volumn 43, Issue 1, 2008, Pages 32-36

  Lo Re III, Vincent ^a   Wertheimer, Benjamin ^b   Localio, A Russell ^a   Kostman, Jay R ^a   Dockter, Janel ^c   Linnen, Jeffrey M ^c   Giachetti, Cristina ^c   Dorey Stein, Zachariah ^a   Frank, Ian ^a   Strom, Brian L ^a   Gross, Robert ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c Gen Probe Incorporated   (United States)

Author keywords

HIV; HIV hepatitis B virus coinfection; Occult hepatitis B virus; Transaminitis

Indexed keywords

AMINOTRANSFERASE; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; RNA;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DATA BASE; DISEASE ASSOCIATION; FEMALE; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TRANSAMINITIS; VIRUS DETECTION;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; COHORT STUDIES; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HIV INFECTIONS; HUMANS; LIVER; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POISSON DISTRIBUTION; STATISTICS, NONPARAMETRIC;

EID: 49749105603     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.03.030     Document Type: Article

References (23)

1. Brechot C., Thiers V., Kremsdorf D., Nalpas B., Pol S., and Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?. Hepatology 34 1 (2001) 194-203
2. Cacciola I., Pollicino T., Squadrito G., Cerenzia G., Orlando M.E., and Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 341 1 (1999) 22-26
3. Conjeevaram H.S., and Lok A.S. Occult hepatitis B virus infection: a hidden menace?. Hepatology 34 1 (2001) 204-206
4. De Maria N., Colantoni A., Friedlander L., Leandro G., Idilman R., Harig J., et al. The impact of previous HBV infection on the course of chronic hepatitis C. Am J Gastroenterol 95 12 (2000) 3529-3536
5. Filippini P., Coppola N., Pisapia R., Scolastico C., Marrocco C., Zaccariello A., et al. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy. AIDS 20 9 (2006) 1253-1260
6. Hofer M., Joller-Jemelka H.I., Grob P.J., Luthy R., and Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis 17 1 (1998) 6-13
7. Hu K.Q. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 9 4 (2002) 243-257
8. Kannangai R., Vivekanandan P., Netski D., Mehta S., Kirk G.D., Thomas D.L., et al. Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection. J Clin Virol 39 2 (2007) 101-105
9. Katkov W.N., Friedman L.S., Cody H., Evans A., Kuo G., Choo Q.L., et al. Elevated serum alanine aminotransferase levels in blood donors: the contribution of hepatitis C virus. Ann Intern Med 115 11 (1991) 882-884
10. Kratz A., and Lewandrowski K.B. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values, N Engl J Med 339 15 (1998) 1063-1072
11. Kubo S., Tamori A., Ohba K., Shuto T., Yamamoto T., Tanaka H., et al. Previous or occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma without hepatic fibrosis. Dig Dis Sci 46 11 (2001) 2408-2414
12. Linnen J., and Phelps B. Implementation of Procleix Ultrio Assay on the Procleix TIGRIS system: a fully automated Triplex NAT Assay. Presented at IPFA/PEI 12th NAT Workshop on Surveillance and Screening of Bloodborne Pathogens. Bethesda, MD (2005)
13. Lo Re III V., Frank I., Gross R., Dockter J., Linnen J.M., Giachetti C., et al. Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients. J Acquir Immune Defic Syndr 44 3 (2007) 315-320
14. McCormick M.K., Dockter J., Linnen J.M., Kolk D., Wu Y., and Giachetti C. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA. J Clin Virol 36 3 (2006) 166-176
15. Nunez M., Rios P., Perez-Olmeda M., and Soriano V. Lack of 'occult' hepatitis B virus infection in HIV-infected patients. AIDS 16 15 (2002) 2099-2101
16. Paterlini P., Driss F., Nalpas B., Pisi E., Franco D., Berthelot P., et al. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology 17 1 (1993) 20-29
17. Pollicino T., Squadrito G., Cerenzia G., Cacciola I., Raffa G., Crax A., et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 126 1 (2004) 102-110
18. Raimondo G. Occult hepatitis B virus infection and liver disease: fact or fiction?. J Hepatol 34 3 (2001) 471-473
19. Raimondo G., Pollicino T., and Squadrito G. What is the clinical impact of occult hepatitis B virus infection?. Lancet 365 9460 (2005) 638-640
20. Rosner B. Fundamentals of biostatistics (2000), Duxbury, Pacific Grove
21. Shibata Y., Nakata K., Tsuruta S., Hamasaki K., Hayashida Y., Kato Y., et al. Detection of hepatitis B virus X-region DNA in liver tissue from patients with hepatitis C virus-associated cirrhosis who subsequently developed hepatocellular carcinoma. Int J Oncol 14 6 (1999) 1153-1156
22. Shire N.J., Rouster S.D., Rajicic N., and Sherman K.E. Occult hepatitis B in HIV-infected patients. J Acquir Immune Defic Syndr 36 3 (2004) 869-875
23. Torbenson M., and Thomas D.L. Occult hepatitis B. Lancet Infect Dis 2 8 (2002) 479-486